Home » Articles » News

Acting mayor stops clinical trials by Chinese firm for vaccine against COVID-19 in Cebu City | Inquirer News...

Acting mayor stops clinical trials by Chinese firm for vaccine against COVID-19 in Cebu City | Inquirer News
"Brendan McDermid/File Photo
CEBU CITY––Acting City Mayor Michael Rama on Monday temporarily stopped the clinical trial for an anti-COVID-19 vaccine conducted by a Chinese firm in this city.
Rama said WestVac Biopharma R&D from Sichuan in China did not coordinate with the city government before conducting the trials.
ADVERTISEMENT

“We only wanted the firm to coordinate with the city like having a MOA (memorandum of agreement) or whatever it is. We need to have an agreement because the city might be held answerable if something bad happens to those who took part in the clinical trials,” he said.
Councilor David Tumulak said trial participants informed him that they were given P2,500 to P5,000 whenever they passed the screening.FEATURED STORIES

NEWSINFO
Roque bares Sara Duterte’s last-minute appeal for him to run for Senate

NEWSINFO
‘Saving’ Manila Bay: Dolomite beach, wetlands drowning in wastes

NEWSINFO
Bongbong, family attend China embassy’s photo wall ribbon-cutting event

He expressed fears that the clinical trials would expose residents to danger.
In a statement sent Friday to reporters, WestVac Biopharma R&D said the participation in the clinical trial was voluntary.

Recommended videosPowered by AnyClip1/7North Korea says US overreacting over missile testRead More



12.1K



3





Video Player is loading.Play VideoUnmuteDuration /Current Time Playback Speed Settings1xLoaded: 0%Remaining Time - FullscreenPlayUp NextThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsReset restore all settings to the default valuesDoneClose Modal DialogEnd of dialog window.Playback Speed0.25x0.5x1x Normal1.5x2xReplay the listPowered by AnyClip Privacy Policy

TOP ARTICLES







































North Korea says US overreacting over missile test
NOW PLAYING
UP NEXT





Ethiopia hits Tigray's capital with third airstrike
NOW PLAYING
UP NEXT





Isko Moreno promises to cut tax on fuel, electricity by 50%
NOW PLAYING
UP NEXT





WATCH: OCEAN PARK SA MANILA, BUKAS NA | CHONA YU
NOW PLAYING
UP NEXT





WATCH: MGA MAGSASAKA, UMAARAY NA SA SMUGGLING NG GULAY NA GALING CHINA | CHONA YU
NOW PLAYING
UP NEXT





WATCH: MGA MAGSASAKA, SUMUGOD SA MENDIOLA | CHONA YU
NOW PLAYING
UP NEXT





Atienza: Makabayan endorses Pacquiao
NOW PLAYING
UP NEXT



North Korea says US overreacting over missile test





“The study team conducts clinical research in a manner that recognizes the importance of protecting the safety and respecting research participants,” it said.
“All research participants have the right to withdraw from continued participation in the clinical trial at any time without penalty or loss of benefits to which they are otherwise entitled,” it added.
Dr. Jaime Bernadas, director of the Department of Health in Central Visayas, said he was told that the Chinese firm got permission from the central office in Manila.
However, WestVac Biopharma Co. Ltd. also did not coordinate with his office.
lzb
.inline_ffff input { width: 70%!important; }
.bypro {
float: right;
width: 71%;
text-align: center;
margin-top: -12px;
margin-right: 15px;
clear: both;
color: #5C5C5C;
font-size: 8px!important;
line-height: 9px!important;

}
.lfform-inquirer-horizontal h2 {
font-weight: bold !important;
font-family: mallory !important;
}
@media only screen and (min-width: 360px) and (max-width: 767px) {
.lfform-inquirer-horizontal #myForm3 {
width: 100%;
display: flex;
flex-wrap: wrap;
justify-content: center;
}
.lfform-inquirer img {
width: 100% !important;
margin: 0 !important;
}
.bypro {
margin-top: 10px;
}
.lfform-inquirer-horizontal input[type=""email""] {

width: 100% !important;
}
.lfform-inquirer-horizontal input[type=""submit""], .lfform-inquirer-horizontal input[type=""button""] {

width: 100% !important;
}
}

.formv4 {
width: 100%!important;
max-width: 100%;
margin: 15px 0;
}
.formv4 input[type=""email""] {
font-weight: bold;
float: left;
-webkit-appearance: none;
margin: 0!important;
width: 70% !important;
}
.formv4 input[type=""submit""] {
font-weight: bold;
width: 28% !important;
padding: 3%;
float: left;
-webkit-appearance: none;
}
.formv4 #myForm3 {
width: 100%;
display: flex;
flex-wrap: wrap;
justify-content: space-between;
}
.formv4 .bypro {
width:100%;
font-family: 'noto serif';
float: unset;
clear: both;
color: #333333;
font-size: 11px!important;

line-height: 1 !important;
margin: 10px 3px;
text-align:left;
}
.formv4 a, .formv4 a:visited, .formv4 a:hover {
color: #0b72b5 !important;
text-decoration: none; !important;
}

.formv4 h2 {
font-weight: bold !important;
text-align: left;
font-family: mallory !important;
color: #333333 !important;
margin:5px 0 !important;
padding: 0 !important;
}
.formv4 p {
width: 100%;
text-align: left;
color: #5A5A5A !important;
font-family: 'noto serif' !important;
font-size: 14px !important;
margin: 0 !important;
line-height: 1.6em !important;
margin-bottom: 15px !important;
padding: 0 !important;
}

@media only screen and (min-width: 360px) and (max-width: 767px) {
.formv4 h2 {

font-size: 16px !important;
}
.formv4 .bypro {
font-size: 12px!important;
margin: 5px 5px;
}
.formv4 input[type=""email""] {

width: 100% !important;
}
.formv4 input[type=""submit""] {
width: 100% !important;
margin: 10px 0;
}
.formv4 {
width: 95%!important;
max-width: 95%;
margin: 20px auto;
}
}

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.

What you need to know about Coronavirus.

For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

#inqplus-article2 {
width: 100%;
height: 250px;
margin: 20px auto;
background-color: #a5b8c5;
display: flex;
flex-wrap: wrap;
justify-content: space-between;
align-items: flex-start;
}
#inqplus-cta-wrap {
width: 50%;
height: 250px;
background-image: url(/single2017/images/inqplus-sub/inqplus-cta-bg1.png);
background-repeat: no-repeat;
background-size: cover;
}
#inqplus-cta2 {
width: 89%;
height: auto;
margin: 35px auto 0;
}
#inqplus-cta2 img {
width: 100%;
}
#newsletter-cta-wrap {
width: 50%;
height: 250px;
background-image: url(/single2017/images/inqplus-sub/newsletter-bg1.png);
position: relative;
background-repeat: no-repeat;
background-size: cover;
}
#newsletter-cta2 {
width: 95%;
position: absolute;
bottom: -4px;
z-index: 1;
}
#newsletter-cta2 img {
width: 100%;
}
#inqplus-nl-sub2 {
width: 65%!important;
display: flex;
font-size: 0;
box-sizing: border-box;
z-index: 2;
position: absolute;
bottom: 10px;
right: 10px;
}
#inqplus-nl-sub2 form {
width: 100%!important;
}
.sub-input2 {
width: 70%!important;
height: 25px!important;
border: 0!important;
padding: 5px 0 5px 10px!important;
margin: 0!important;
box-sizing: border-box!important;
border-radius:0;
-webkit-appearance:none;
}
.sub-btn2 {
width: 30%!important;
height: 25px!important;
border: 0!important;
padding: 0!important;
margin: 0!important;
background-color: #004a87!important;
color: #f5f5f5!important;
text-transform: uppercase!important;
border-radius:0;
-webkit-appearance:none;
}
/* 414px */
@media only screen and (min-width: 414px) and (max-width: 599px){
#inqplus-article2 {
width: 98%;
height: auto;
}

#inqplus-cta-wrap {
width: 100%;
height: auto;
}

#newsletter-cta-wrap {
width: 100%;
}

#newsletter-cta2 img {
width: 90%;
}

}

/* 320px */
@media only screen and (min-width: 320px) and (max-width: 413px){
#inqplus-article2 {
width: 98%;
height: auto;
}

#inqplus-cta-wrap {
width: 100%;
}

#newsletter-cta-wrap {
width: 100%;
}

}

Read Next

Eleazar deploys more cops in NCR amid shift to less restrictive quarantine

VerrulonRemove Warts & Skin Tags Safely At Home! Try Out Now!Verrulon|SponsoredSponsoredUndoStudent SeaKate Middleton's Daring Outfit Took Prince William's Breath AwayStudent Sea|SponsoredSponsoredUndoBETER - leading providerSports betting odds, api for sportsbooksBETER - leading provider|SponsoredSponsoredUndoTips and TricksA Marine rushes home to greet his wife, but is surprised when he sees her.Tips and Tricks|SponsoredSponsoredUndoArticles SkillDean Martin's Daughter Finally Confirms the RumorsArticles Skill|SponsoredSponsoredUndoAtlantic MirrorJada Pinkett Smith Revealed How She Really Felt After Her Son's Sudden DecisionAtlantic Mirror|SponsoredSponsoredUndoAcuStepsAng simpleng pamamaraan na ito ay aalisin ang sakit ng buong katawan. Subukan ito ngayong gabi!AcuSteps|SponsoredSponsoredUndo

window._taboola = window._taboola || [];
_taboola.push({
mode: 'thumbnails-d',
container: 'taboola-below-article-thumbnails-desktop',
placement: 'Below Article Thumbnails - newsinfo',
target_type: 'mix'
});


window._taboola = window._taboola || [];
_taboola.push({
mode: 'thumbnails-e',
container: 'taboola-below-article-thumbnails-mobile',
placement: 'Below Article Thumbnails - newsinfo',
target_type: 'mix'
});

EDITORS' PICK

DOJ drug war review: Killer cops had it easy

Next level mobile photography within reach with vivo X70 co-engineered with ZEISS

Leaked: A 60x Zoom and all-new Helio G96 mean a complete overhaul for TECNO Mobile’s new CAMON 18 series

Pagasa: Fair weather on Thursday; cooler days coming

US FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost

Delivering delight against all odds

MOST READ

Drilon: Tax and then ban Chinese firm in pandemic funds mess

‘Saving’ Manila Bay: Dolomite beach, wetlands drowning in wastes

US FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost

Villar scolds DENR over ‘scant’ funding proposal for protected areas

Don't miss out on the latest news and information.

View comments"
 

Please support us in writing articles like this by sharing this post

Share this post to your Facebook, Twitter, Blog, or any social media site. In this way, we will be motivated to write articles you like.

--- NOTICE ---
If you want to use this article or any of the content of this website, please credit our website (www.affordablecebu.com) and mention the source link (URL) of the content, images, videos or other media of our website.

"Acting mayor stops clinical trials by Chinese firm for vaccine against COVID-19 in Cebu City | Inquirer News" was written by Mary under the News category. It has been read 81 times and generated 0 comments. The article was created on and updated on 17 November 2021.
Total comments : 0